YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

Novo Nordisk shares jump on drug trial results

Posted online

Novo Nordisk shares jumped 14% on news of drug trial results for its once weekly amycretin obesity drug.

Trial participants had an average weight reduction of 22%.

The company's stock is reportedly on track for its biggest daily gain since August 2023.

Read more from CNBC.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
Annual downtown holiday events combine for Nov. 21 celebration

Organizers hope to bolster client traffic to center city businesses.

Most Read
SBJ.net Poll
How often do you use artificial intelligence for your business?

*

View results

Update cookies preferences